Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huatuo Guoyao is a prominent Chinese pharmaceutical company headquartered in Bozhou, Anhui Province, a city historically recognized as the capital of Traditional Chinese Medicine (TCM). The company specializes in the research, development, and large-scale manufacturing of TCM preparations, modern chemical drugs, and health supplements. Its extensive product portfolio includes various dosage forms such as pills, tablets, capsules, and granules, with a particular focus on cardiovascular health, respiratory ailments, and chronic disease management. Named after the legendary physician Hua Tuo, the company leverages a strong heritage brand to maintain a significant market share in China's domestic pharmaceutical industry. Huatuo Guoyao operates modern, GMP-certified facilities and integrates traditional herbal wisdom with contemporary pharmacological standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huatuo Guoyao.